Physician profile
Stephen Schnulo
NPI 1013093871
$4,574.22
in general payments reported to CMS, 2019-2025
15 companies · $468 in 2025
The $468 reported for 2025 was more than what 75% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $938 · 2020: $553 · 2021: $786 · 2022: $728 · 2023: $683 · 2024: $418 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,530 · Entertainment: $38.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,530.40 |
| Entertainment | $38.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $934.73 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $917.99 | 2019-2025 | Total30, Dailies Total1, Precision7 |
| Coopervision INC. | $859.98 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $735.97 | 2019-2021 | |
| Lombart Brothers, INC. | $389.28 | 2019-2025 | Opd-III |
| Bausch & Lomb Americas INC. | $214.64 | 2022-2025 | Infuse, Miebo, Xiidra |
| Topcon Healthcare, INC. | $180.34 | 2021 | |
| Sun Pharmaceutical Industries INC. | $130.82 | 2021-2025 | Cequa |
| Kala Pharmaceuticals, INC. | $46.45 | 2021-2022 | |
| Optos, INC. | $38.46 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $35.39 | 2021-2022 | |
| Allergan, INC. | $32.41 | 2020-2022 | |
| Sight Sciences, INC. | $21.48 | 2020 | |
| Oyster Point Pharma, INC. | $20.26 | 2022 | |
| Biotissue Holdings INC. | $16.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Schnulo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.